Dupilumab Interactions
There are 94 drugs known to interact with dupilumab, along with 3 disease interactions. Of the total drug interactions, 43 are major, 42 are moderate, and 9 are minor.
- View all 94 medications that may interact with dupilumab
- View dupilumab disease interactions (3)
Most frequently checked interactions
View interaction reports for dupilumab and the medicines listed below.
- Ativan (lorazepam)
- Benadryl (diphenhydramine)
- Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- Cialis (tadalafil)
- Claritin (loratadine)
- CoQ10 (ubiquinone)
- Dextrose (glucose)
- Diltiazem Hydrochloride SR (diltiazem)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Fosamax (alendronate)
- Levaquin (levofloxacin)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Mounjaro (tirzepatide)
- Nexium (esomeprazole)
- Paracetamol (acetaminophen)
- ProAir HFA (albuterol)
- Singulair (montelukast)
- Spiriva Respimat (tiotropium)
- Symbicort (budesonide / formoterol)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
- Zinc (zinc sulfate)
Dupilumab disease interactions
There are 3 disease interactions with dupilumab which include:
More about dupilumab
- dupilumab consumer information
- Compare alternatives
- Reviews (525)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.